Source: 7activestudio/Getty Images

Protein Breast Cancer Biomarker Indicates Likelihood of Recurrence, Mortality

The amount of the protein, NR2F1, present indicates whether a breast cancer patient will likely relapse and develop deadly bone metastases
Source: Thermo Fisher Scientific

Thermo Fisher Intros New Benchtop NGS Line, Expands Oncomine Assay Offerings

The Ion GeneStudio S5 series' multichip design offers flexibility, while Oncomine portfolio adds liquid biopsy and immuno-oncology assays
Personal Genome Diagnostics has won a contract from the U.S. Department of Veterans Affairs (VA) to provide its PlasmaSELECT™ 64 liquid biopsy profiling assay to advanced cancer patients being treated at VA facilities.. [iStock/©dmbaker]

VA Agrees to Use Second PGDx Cancer Assay for Patient Testing

PlasmaSELECT will be the first plasma-based genomic profiling test offered to VA cancer patients, and the first to also include MSI testing.

Discovery of Functional Serum Biomarkers

Lung cancer is one of the most common malignancies and the leading cause of cancer-related fatality. In the United States alone, more than 210,000...
Source: Penn Medicine

Promise of Liquid Biopsy Enhanced by New Study Results

New research will be presented at the 2017 annual meeting of the American Association for Cancer Research (AACR).
Source: Getty Images

CellMax Life, IncellDx to Jointly Market and Develop CTC-based Liquid Biopsy Diagnostics

The combined offering is aimed at addressing the limitations of tissue-based PD-L1 testing that can hamper immunotherapy clinical trials
Johnson & Johnson’s Janssen Research & Development will use BiomX's XMarker platform to discover microbiome-based biomarkers for inflammatory bowel disease (IBD)

Janssen, BiomX to Partner on Discovering Microbiome-Based IBD Biomarkers

Janssen will use BiomX's XMarker platform to stratify responders versus non-responders of inflammatory bowel disease therapeutics
An increasing number of clinicians are adding the cancer transcriptome to their precision medicine program. They have found that the transcriptome is important in identifying clinically impactful results. [iStock / DeoSum]

Deciphering the Cancer Transcriptome

A variety of malignant outliers may hide in transcriptome profiles that emphasize averages.
To make better use of genomics data

Near or Far? Omics Data Management, Analysis, and Action

It was inspiring to listen to Howard J. Jacob, Ph.D., professor of physiology and human and molecular genetics at Medical College of Wisconsin, speaking...
HTG Molecular Diagnostics will partner with Oncologie to develop biomarkers for use with Oncologie's pipeline of immuno-oncology treatments. [Source: © dimdimich/Fotolia]

HTG, Oncologie Partner to Develop Cancer Immunotherapy Biomarkers

Companies to partner on biomarkers for Oncologie's pipeline, which includes the Phase III lefitolimod and the Phase II bavituximad
Scroll Up